Premature ovarian failure is not premature menopause

Annals of the New York Academy of Sciences

Volumn 900, Issue , 2000, Pages 393-402

  Kalantaridou, Sophia N ^a   Nelson, Lawrence M ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; ESTROGEN; FOLLITROPIN; GESTAGEN; GONADORELIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; SEX HORMONE;

CONFERENCE PAPER; EARLY MENOPAUSE; ESTROGEN THERAPY; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; MENOPAUSE; OVARY FOLLICLE; OVARY FUNCTION; OVULATION; PREGNANCY;

POMACANTHUS MACULOSUS;

EID: 0034017221     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06251.x     Document Type: Conference Paper

References (57)

1. 1. NELSON, L.M., J.N. ANASTI & M.R. FLACK. 1996. Premature ovarian failure. In Reproductive Endocrinology, Surgery, and Technology. E.Y. Adashi, J.A. Rock & Z. Rosenwaks, Eds.: 1394-1410. Lippincott-Raven Publishers. Philadelphia, PA.
2. 2. COULAM, C.B., S.C. ADAMSON & J.F. ANNEGERS. 1986. Incidence of premature ovarian failure. Obstet. Gynecol. 67: 604-606.
3. 3. NELSON, L.M., J.N. ANASTI, L.M. KIMZEY et al. 1994. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J. Clin. Endocrinol. Metab. 79: 1470-1475.
4. 4. ALPER, M.M., E.E. JOLLY & P.R. GARNER. 1986. Pregnancies after premature ovarian failure. Obstet. Gynecol. 67(Suppl): 59-62.
5. 5. KALANTARIDOU, S.N., S.R. DAVIS & L.M. NELSON. 1998. Premature ovarian failure. Endocrinol. Metab. Clin. N. Am. 27. In press.
6. 6. COOPER, G.S. & D.P. SANDLER. 1998. Age at natural menopause and mortality. Ann. Epidemiol. 8: 229-235.
7. 7. SNOWDON, D.A., R.L. KANE, W.L. BEESON et al. 1989. Is early natural menopause a biologic marker of health and aging? Am. J. Public Health 79: 709-714.
8. 8. RICHARDSON, S.J. & J.F. NELSON. 1990. Follicular depletion during the menopausal transition. Ann. N.Y. Acad. Sci. 592: 13-20.
9. 9. REBAR, R.W. & H.V. CONNOLLY. 1990. Clinical features of young women with hypergonadotropic amenorrhea. Fertil. Steril. 53: 804-810.
10. 10. DUNCAN, M., L. CUMMINGS & K. CHADA. 1993. Germ cell deficient (gcd) mouse as a model of premature ovarian failure. Biol. Reprod. 49: 221-227.
11. 11. BAKER, T.G. & O.W. SUM. 1976. Development of the ovary and oogenesis. Clin. Obstet. Gynecol. 3: 3-26.
12. 12. BURGER, H.G., N. CAHIR, D.M. ROBERTSON et al. 1998. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin. Endocrinol. 48: 809-813.
13. 13. REBAR, R.W. & M.I. CEDARS. 1992. Hypergonadotropic forms of amenorrhea in young women. Endocrinol. Metab. Clin. N. Am. 21: 173-191.
14. 14. KIM, T.J., J.N. ANASTI, M.R. FLACK et al. 1997. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet. Gynecol. 89: 777-779.
15. 15. IRVINE, W.J., M.M.W. CHAN, L. SCARTH et al. 1968. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 2: 7574-7890.
16. 16. BANNATYNE, P., P. RUSSELL & R.P. SHERMAN. 1990. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int. J. Gynecol. Pathol. 9: 191-207.
17. 17. SEDMAK, D.D., W.R. HART & R.R. TUBBS. 1987. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int. J. Gynecol. Pathol. 6: 73-89.
18. 18. NELSON, L.M., L.M. KIMZEY, G.R. MERRIAM et al. 1991. Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. Fertil. Steril. 55: 1082-1087.
19. 19. WALFISH, P.G., I.S. GOTTESMAN, A.B. SHEWCHUK et al. 1983. Association of premature ovarian failure with HLA antigens. Tissue Antigens 21: 168-169.
20. 20. ANASTI, J.N., S. ADAMS, L.M. KIMZEY et al. 1994. Karyotypically normal spontaneous premature ovarian failure: evaluation of association with the class II major histocompatibility complex. J. Clin. Endocrinol. Metab. 78: 722-723.
21. 21. LINDSTROM, J.M., M.E. SEYBOLD, V.A. LENNON et al. 1976. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26: 1054-1059.
22. 22. DREXHAGE, H.A., G.F. BOTTAZZO, L. BITENSKY et al. 1981. Thyroid growth-blocking antibodies in primary myxoedema. Nature 289: 594-596.
23. 23. ANASTI, J.N., M.R. FLACK, I. FROEHLICH et al. 1995. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J. Clin. Endocrinol. Metab. 80: 824-828.
24. 24. AHONEN, P., S. MYLLÄRNIEMI, I. SIPILÄ et al. 1990. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 322: 1829-1836.
25. 25. THE FINNISH-GERMAN APECED CONSORTIUM. 1997. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genet. 17: 399-403.
26. 26. NAGAMINE, K., P. PETERSON, H.S. SCOTT et al. 1997. Positional cloning of the APECED gene. Nature Genet. 17: 393-398.
27. 27. MATTHEWS, C.H., S. BORGATO, P. BECK-PECCOZ et al. 1993. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nature Genet. 5: 83-86.
28. 28. LAYMAN, L.C., E.J. LEE, D.B. PEAK et al. 1997. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N. Engl. J. Med. 337:607-611.
29. 29. AITTOMÄKI, K., J.L.D. LUCENA, P. PAKARINEN et al. 1995. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotrophic ovarian failure. Cell 82: 959-968.
30. 30. AITTOMÄKI, K., R. HERVA, U.H. STENMAN et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J. Clin. Endocrinol. Metab. 81: 3722-3726.
31. 31. LATRONICO, A.C., J.N. ANASTI, I.J.P. ARNHOLD et al. 1996. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N. Engl. J. Med. 334: 507-512.
32. 32. ARNOLD, I.J.P., A.C. LATRONICO, M.C. BATISTA et al. 1997. Ovarian resistance to luteinizing hormone: a novel cause of amenorrhea and infertility. Fertil. Steril. 67: 394-397.
33. 33. TOLEDO, S.P.A., H.G. BRUNNER, R. KRAAIJ et al. 1996. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J. Clin. Endocrinol. Metab. 81: 3850-3854.
34. 34. KATER, C.E. & E.G. BIGLIERI. 1994. Disorders of steroid 17 alpha-hydroxylaxion deficiency. Endocrinol. Metab. Clin. N. Am. 23: 341-357.
35. 35. ZACHMANN, M. 1995. Defects in steroidogenic enzymes: discrepancies between clinical steroid research and molecular biology results. J. Steroid Biochem. Mol. Biol. 53: 159-164.
36. 36. PELLICER, A., F. MIRO, M. SAMPAIO et al. 1991. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20 desmolase deficiency. Fertil. Steril. 55: 970-975.
37. 37. KOYAMA, H., T. WADA, Y. NISHIZAWA et al. 1977. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 39: 1403-1409.
38. 38. STILLMAN, R.J., J.S. SCHINFELD, I. SCHIFF et al. 1981. Ovarian failure in long-term survivors of childhood malignancy. Am. J. Obstet. Gynecol. 139: 62-66.
39. 39. SARTO, G.E. 1974. Cytogenetics of fifty patients with primary amenorrhea. Am. J. Obstet. Gynecol. 119: 14-23.
40. 40. KRAUSS, C.M., R.N. TURKSOY, L. ATKINS et al. 1987. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N. Engl. J. Med. 317: 125-131.
41. 41. POWELL, C.M., R.T. TAGGART, T.C. DRUMHELLER et al. 1994. Molecular and cytogenetic studies of an X;autosome translocation in a patient with premature ovarian failure and review of the literature. Am. J. Med. Genet. 52:19-26.
42. 42. BIONE, S., C. SALA, C. MANZINI et al. 1998. A human homologue of the Drosophila diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am. J. Med. Genet. 62: 533-541.
43. 43. SCHWARTZ, C.E., J. DEAN, P.N. HOWARD-PEEBLES et al. 1994. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am. J. Med. Genet. 51:400-402.
44. 44. CONWAY, G.S., N.N. PAYNE, J. WEBB et al. 1998. Fragile X premutation screening in women with premature ovarian failure. Hum. Reprod. 13: 1184-1187.
45. 45. WAGGONER, D.D., N.R.M. BUIST & G.N. DONNELL. 1990. Long-term prognosis in galactosemia: results of a survey of 350 cases. J. Inherit. Metab. Dis. 13: 802-818.
46. 46. DAVIS, S.R. 1996. Premature ovarian failure. Maturitas 28: 1-8.
47. 47. ANASTI, J.N., S.N. KALANTARIDOU, L.M. KIMZEY et al. 1998. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet. Gynecol. 91:12-15.
48. 48. CUMMINGS, S.R., D.M. BLACK, M.C. NEVITT et al. 1993. Bone density at various sites for prediction of hip fractures. Lancet 341: 72-75.
49. 49. WRIGHT, C.S.W. & H.S. JACOBS. 1979. Spontaneous pregnancy in a patient with hypergonadotropic ovarian failure. Br. J. Obstet. Gynaecol. 86: 389-392.
50. 50. SHAPIRO, A.G. & A. RUBIN. 1977. Spontaneous pregnancy in association with hypergonadotropic ovarian failure. Fertil. Steril. 28: 500-501.
51. 51. JOHNSON, T.R. & E.P. PETERSON. 1979. Gonadotropin induced pregnancy following "premature ovarian failure." Fertil. Steril. 31: 351-352.
52. 52. VAN KASTEREN, Y.M., A. HOEK & J. SCHOEMAKER. 1995. Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertil. Steril. 64: 273-278.
53. 53. NELSON, L.M., L.M. KIMZEY, B.J. WHITE et al. 1992. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled study. Fertil. Steril. 57: 50-55.
54. 54. ANASTI, J.N., L.M. KIMZEY, R.A. DEFENSOR et al. 1994. A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure. Fertil. Steril. 62: 726-730.
55. 55. LYDIC, M.L., J.H. LIU & R.W. REBAR. 1996. Success of donor oocyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure. Fertil. Steril. 65: 98-102.
56. 56. NAVOT, D., M.R. DREWS, P.A. BERGH et al. 1994. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantantion. Fertil. Steril. 61: 97-101.
57. 57. LUBORSKY, J.L., I. VISINTIN, S. BOYERS et al. 1990. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J. Clin. Endocrinol. Metab. 70: 69-75.